2025 is shaping up to be a blockbuster year in diabetes care! From smart MDI systems to medications that pull triple duty, the future is looking smarter—and less invasive.
Here are several key advancements we expect to see in 2025.
Dr. E’s 85-year-old patient José came to his last endo appointment with a stellar CGM report. Jose’s download stated that his time in range was 78%, his average glucose was 146 mg/dL, and his estimated A1c was 6.8% without any low blood sugars. But a very important data point was missing from the CGM report’s overview, providing an important reminder for both patients and providers.
read more →
When diabetes lives with you day-to-day like a stage five clinger, it can be easy to feel like advancements in care aren’t happening at a fast enough pace. But we’re here to tell you, things are happening! Here’s a short list of some of the progress we saw in 2024, including new pumps, new CGMs, and exciting research studies with promising results.
read more →
If you have type 2 diabetes, it’s time to get PUMPED! Insulin pumps are becoming more available for people with T2D, and it’s about time. Never worn a pump before? No problem…Drs. E+P explain how they work, key features, basal and bolus options, current pumps on the market, and a new pump designed for the type 2 community that’s coming soon.
read more →
History has been just been made! The first-ever year-long CGM sensor was recently approved by the FDA. The Eversense 365 is an implantable CGM that’s cleared for use in people 18 years and older with type 1 or type 2 diabetes. It offers several unique benefits including on-body vibration alerts and a removable transmitter.
read more →